Patents by Inventor Catherine M. Shachaf

Catherine M. Shachaf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11744510
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: September 5, 2023
    Assignee: ORLUCENT INC.
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20220061749
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Application
    Filed: November 9, 2021
    Publication date: March 3, 2022
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Patent number: 11185278
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: November 30, 2021
    Assignee: Orlucent, Inc.
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Patent number: 10531824
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: January 14, 2020
    Assignee: ORLUCENT, INC.
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20190307391
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Application
    Filed: November 8, 2018
    Publication date: October 10, 2019
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Patent number: 10165976
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: January 1, 2019
    Assignee: Orlucent, Inc.
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20170049380
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Application
    Filed: November 7, 2016
    Publication date: February 23, 2017
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20140350395
    Abstract: Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc.
    Type: Application
    Filed: December 21, 2012
    Publication date: November 27, 2014
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20140314661
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Application
    Filed: January 22, 2014
    Publication date: October 23, 2014
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Patent number: 8642009
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: February 4, 2014
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20110311970
    Abstract: Compositions and methods for multiplex immunodetection of analytes in single cells or cell populations are described. The invention utilizes analytical nanotags (ANTs) each specific for a different target analyte (TA) species. Analytical nanotags typically comprise biocompatible composite organic-inorganic nanoparticles (bCOINs) that include probe molecules specific for a particular TA species. A plurality of ANTs each specific for a different TA species can be used in a single multiplex assay, including assays for analyzing intracellular analytes in living cells.
    Type: Application
    Filed: April 14, 2011
    Publication date: December 22, 2011
    Inventors: Catherine M. SHACHAF, Garry P. NOLAN
  • Publication number: 20090220415
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Application
    Filed: December 18, 2006
    Publication date: September 3, 2009
    Inventors: Catherine M. Shachaf, Amit Shachaf